Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Hyperbilirubinemia, Augmentation of Endothelial Function, and Decrease in Oxidative Stress in Gilbert Syndrome

(2012) Tatsuya Maruhashi et al.   CIRCULATION

Serum Bilirubin Level is Negatively Correlated With Disease Progression of Peripheral Arterial Disease

(2011) Hai-Yang Wang et al.   ANGIOLOGY

Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential

(2011) Kim H. Chan et al.   CLINICAL SCIENCE

Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?

(2011) Lars H. Breimer et al.   CURRENT PHARMACEUTICAL DESIGN

Plasma Bilirubin and UGT1A1*28 Are Not Protective Factors Against First-Time Myocardial Infarction in a Prospective, Nested Case–Referent Setting

(2010) Kim Ekblom et al.   Circulation-Cardiovascular Genetics

Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease

(2010) J.-P. Lin et al.   CLINICAL CHEMISTRY

Bilirubin Is Negatively Associated With A1C Independently of Fasting Plasma Glucose, Age, Obesity, Inflammation, Hemoglobin, and Iron in Apparently Healthy Japanese Men and Women

(2010) E. Oda   DIABETES CARE

Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women

(2010) Keizo Ohnaka et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)

(2009) Nicola Lüblinghoff et al.   BMC Medical Genetics

Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?

(2009) Serkan Tapan et al.   CLINICAL BIOCHEMISTRY

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

(2009) Kushwin Rajamani et al.   LANCET

Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence

(2009) Heejin Kimm et al.   STROKE

Therapeutic Angiogenesis for Critical Limb Ischemia

(2008) Jörn Tongers et al.   CIRCULATION

Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study

(2008) B. Rantner et al.   CLINICAL CHEMISTRY

Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients

(2008) Y.-H. Chen et al.   DIABETES CARE

Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population: A 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations

(2008) A. Johannesson et al.   DIABETES CARE

Pharmacological and Clinical Aspects of Heme Oxygenase

(2008) N. G. Abraham et al.   PHARMACOLOGICAL REVIEWS

Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease

(2007) Todd S. Perlstein et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY